Wickramasinghe Nilmini, John Blooma, George Joey, Vogel Doug
Swinburne University of Technology, Hawthorn, Australia.
Epworth HealthCare, Richmond, Australia.
JMIR Diabetes. 2019 May 3;4(2):e10368. doi: 10.2196/10368.
The World Health Organization notes that diabetes, a chronic disease, is a silent epidemic, and by 2020 there will be a 54% rise in the total number of individuals diagnosed with this disease. These are alarming figures that have significant repercussions for the quality of life of individuals and their families as well as for the financial stress of health care systems globally. Early detection and proactive management of diabetes is essential. The Diamond solution provides diabetes self-management by enabling patients to send details about their blood sugar readings at specific times to their nominated care coordinator to receive recommendations for diet and exercise and insulin titration.
The aim of the study was to assess the usability, acceptability, and fidelity of the Diamond diabetes monitoring device for patients with gestational diabetes mellitus (GDM). Specifically assessed were (1) patient compliance, (2) patient satisfaction, (3) level of glycemic control achieved, and (4) health professional satisfaction.
Using a design science research perspective, the Diamond diabetes monitoring device solution was adapted to the Australian health care environment. Once the solution was deemed fit for purpose by the director of the OB/GYN clinical institute and on securing all relevant ethics approvals, a 2-period 2-arm nonblinded crossover clinical trial was conducted for 8 weeks total time with crossover at 4 weeks to establish proof of concept, usability, and fidelity. The patient perspective was assessed by using structured questionnaires at 4 specific stages of the project, while the clinician perspective was captured via semistructured interviews and unstructured questionnaires.
The 10 patients studied reported preferring standard care with the technology solution to standard care alone. Further, all clinicians involved concurred that the technology solution greatly assisted their ability to provide higher value patient-centered care. They also noted that it was extremely helpful for assisting in systematically monitoring glucose levels and any/all changes and trends.
Based on these initial findings, we offer a holistic pervasive approach to enable the achievement of value-based, patient-centered care in chronic disease management. Key lessons include the importance when designing such solutions to focus on the two primary user groups (patients and clinicians).
世界卫生组织指出,糖尿病作为一种慢性病,正悄然蔓延,到2020年,糖尿病确诊患者总数将增长54%。这些数字令人担忧,对个人及其家庭的生活质量以及全球医疗保健系统的经济压力都产生了重大影响。糖尿病的早期检测和积极管理至关重要。钻石解决方案通过使患者能够在特定时间将血糖读数细节发送给指定的护理协调员,以获取饮食、运动和胰岛素滴定方面的建议,从而实现糖尿病自我管理。
本研究旨在评估钻石糖尿病监测设备对妊娠期糖尿病(GDM)患者的可用性、可接受性和保真度。具体评估内容包括:(1)患者依从性;(2)患者满意度;(3)血糖控制水平;(4)医护人员满意度。
从设计科学研究的角度出发,将钻石糖尿病监测设备解决方案应用于澳大利亚医疗保健环境。一旦妇产科临床研究所所长认为该解决方案符合目的,并获得所有相关伦理批准,便进行了为期8周的两阶段双臂非盲交叉临床试验,4周时进行交叉,以确立概念验证、可用性和保真度。在项目的4个特定阶段,通过结构化问卷评估患者的观点,同时通过半结构化访谈和非结构化问卷收集临床医生的观点。
参与研究的10名患者表示,比起单纯的标准护理,他们更喜欢采用该技术解决方案的标准护理。此外,所有参与的临床医生都一致认为,该技术解决方案极大地有助于他们提供更有价值的以患者为中心的护理。他们还指出,这对于系统监测血糖水平以及任何/所有变化和趋势非常有帮助。
基于这些初步发现,我们提供了一种全面的普及方法,以在慢性病管理中实现基于价值的、以患者为中心的护理。关键经验教训包括,在设计此类解决方案时,关注两个主要用户群体(患者和临床医生)非常重要。